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ABSTRACT In Xenopus laevis oocytes, adenosine and
other purinergic agonists induce a K+-conductance increase
that is fully mimicked by intracellular application of cAMP.
Acetylcholine suppresses the K+-conductance increase caused
by adenosine, by the phosphodiesterase inhibitor 3-isobutyl-1-
methylxanthine, or by intracellular injection of cAMP. This
effect of acetylcholine is not mimicked by intracellular injection
of Ca2+ or of the Ca-mobilizing agent inositol 1,4,5-trisphos-
phate. However, adenosine and cAMP responses are inhibited
by 4f3-phorbol 12,13-dibutyrate and 4f8-phorbol 12-myristate
13-acetate. These results suggest that, in Xenopus oocytes, the
muscarinic inhibition of purinergic and cAMP responses is
mediated through the activation of the phospholipid-depen-
dent, Ca-activated protein kinase (protein kinase C).
Several hormones and neurotransmitters produce "slow"
membranal responses through changes in the intracellular
levels of second messengers, such as cyclic nucleotides,
calcium, etc. (for reviews, see refs. 1-4). The best known
examples involve activation of adenylate cyclase, followed
by elevation of intracellular cAMP concentration, resulting
protein phosphorylation, and alterations in the gating of ion
channels. This mechanism accounts for the regulation of Ca
channels by B-adrenergic agonists in the heart (see refs. 5 and
6 and references therein) and of K+ channels by neurotrans-
mitters in molluscan neurons (7, 8). Hormones of a second
group [e.g., acetylcholine (AcCho) at the muscarinic recep-
tor] are believed to antagonize the effects of adenylate
cyclase-activating agents either through inhibition of adenyl-
ate cyclase (9, 10) or through activation ofa cyclic nucleotide
phosphodiesterase (11-13). However, resulting effects on
channel gating are not yet fully characterized.
We have chosen the Xenopus laevis oocyte as a model
system for the study of neurotransmitter interactions of the
kind described above. The oocytes exhibit muscarinic (14,
15) and purinergic (16) responses. The dominant response to
bath application of adenosine is an increase in K+ conduc-
tance (16) that is (a) mediated through P1 purinoreceptor
(known to activate adenylate cyclase, ref. 17), (b) associated
with an increase in cAMP level, (c) inhibited by intracellular
injection of protein kinase inhibitors, and (d) mimicked by
intracellular injection of cAMP (36). AcCho, acting on a
muscarinic receptor, causes polyphosphoinositide (phos-
phatidylinositol phosphate) breakdown (18) and also evokes
a complex membrane response, consisting of a biphasic Cl-
current, Cl- current fluctuations, and a less prominent K+
conductance increase (19). The Cl- current response appar-
ently results from an inositol 1,4,5-trisphosphate
[Ins(1,4,5)P3]-mediated increase in the intracellular Ca level
(18, 20). The increase may possibly be accompanied by an
activation of the Ca/calmodulin-dependent phosphodiester-
ase found in the oocytes (21, 22). In addition, AcCho inhibits
adenylate cyclase in the oocyte (23). One may expect,
therefore, that AcCho will antagonize the adenosine re-
sponse.
We report here that AcCho does, indeed, inhibit the
K+-conductance increase evoked by adenosine. We also
present evidence that, surprisingly, this effect does not seem
to be mediated either by adenylate cyclase inhibition or by
the activation of a cyclic nucleotide phosphodiesterase;
rather, activation of protein kinase C appears to be involved.
MATERIALS AND METHODS
Ovarian lobes were removed from adult female Xenopus.
Fully grown, stage 5 and 6 (24) oocytes were separated
manually and used as follicles; i.e., the surrounding cellular
and noncellular layers were not removed. Both adenosine
and AcCho responses in the oocyte originate at the oocyte
membrane (14-16). A single cell was placed in a 1-ml bath,
constantly perfused with either Ringer's or ND96 solution
(pH 7.5, room temperature). The solutions had the following
compositions: Ringer's, 116 mM NaCl/2 mM KCl/1.8 mM
CaCl2/1 mM MgCl2/5 mM Tris/HCl; ND96, 96 mM NaCl/2
mM KCl/1.8 mM CaCl2/1 mM MgCl2/5 mM Hepes/NaOH.
Bath applications of all substances were made without
changing the rate of flow; perfusion "dead time" was 3-6
sec. 4,3-Phorbol 12,13-dibutyrate (PBt2) and 4p-phorbol 12-
myristate 13-acetate (PMA) were dissolved in dimethyl
sulfoxide at 1 mM and stored at -20°C. Dimethyl sulfoxide
did not have any effects on the oocytes' membrane conduc-
tance at concentrations up to 0.3%. Final concentrations of
the phorbol esters were prepared just prior to each experi-
ment. All substances used in the study were purchased from
Sigma; Ins(1,4,5)P3 was generously provided by Y. Oron
(School of Medicine, Tel Aviv University, Israel).
The electrophysiological procedure has been described in
detail (19). Briefly, the cell was penetrated with two conven-
tional 3 M KCl electrodes, voltage-clamped at -50 or -60
mV, and AcCho was applied. The Cl- equilibrium potential
(Vci,eq) was then measured as the reversal potential ofthe fast
or the fluctuational phases of the AcCho response, both
purely Cl- currents (19, 25). The reversal potential of the
fluctuational response was determined by manually changing
the holding potential during a long-lasting application of
AcCho, until the potential at which the fluctuations nullified
was found. The reversal potential of the fast Cl- current was
determined by applying a voltage ramp to the cell; the voltage
and current outputs of the clamp circuit were connected to
the X- and Y-axis inputs, respectively, of a pen recorder. The
Abbreviations: AcCho, acetylcholine; iBuMeXan, 3-isobutyl-1-
methylxanthine; Ins(1,4,5)P3, inositol 1,4,5-trisphosphate; PBt2, 43-
phorbol 12,13-dibutyrate; PMA, 4f3-phorbol 12-myristate 13-acetate;
VcIeq, Cl- equilibrium potential.
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reversal potential of the response was at the intersection of
the voltage-current curves obtained at rest and at the plateau
of the response. Membrane conductance was determined
from the slope of the voltage-current curves at -50 mV
(close to the resting potential value). In the intervals between
drug applications, the voltage-clamp circuit was usually
disconnected, so that no current was applied. A few minutes
before and during the application of the substances under
study, the circuit was reconnected. The intervals between the
subsequent applications of AcCho or adenosine were about
30 min, to avoid the effects of agonist-induced self-refracto-
riness (16, 19).
Intracellular pressure injections of CaCl2 and of Ins(1,4,5)-
P3 were made through an additional micropipette, as de-
scribed (18-20). The injecting pipettes were filled with 10-50
mM CaCl2 (pH 7) or with 1 mM Ins(1,4,5)P3 (pH 7). The
amount of injected substance was determined from the
volume of the drop released by the pipette into paraffin oil
(tested before insertion ofthe pipette into the cell and, in most
cases, after withdrawal). The volume of the injected solution
did not exceed 0.5% of the oocyte volume, and the injection
artifacts were small or negligible (19). cAMP was injected
iontophoretically through a third micropipette containing 0.2
M cAMP (Na salt; pH 7). Injected current was measured by
a virtual-ground amplifier.
RESULTS
First, we tested the prediction that AcCho should antagonize
adenosine-evoked K+ current. To minimize the interference
by the CP- currents, the experiments were performed at
membrane potentials near VcI,eq (unless stated otherwise).
The latter was usually between -20 and -30 mV (19); it was
estimated either in the oocyte under study or in another
oocyte of the same frog (values among cells from the same
donor agreed within +2 mV; ref. 19). Under these conditions,
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AcCho evoked only or predominantly K+ current (e.g., Fig.
1A).
Bath application ofAcCho (1-2 ,M) rapidly suppressed the
K+ current evoked by continuous exposure to adenosine
(Fig. 1). The residual outward current was usually compara-
ble to that evoked by AcCho alone (Fig. 1C). In all cases, the
amplitude of the adenosine response returned to the control
level 20-30 min after AcCho washout. The effect of AcCho
was blocked by 1 ,uM atropine (three cells).
The inhibition by AcCho of the adenosine-evoked K+
conductance increase was studied further in oocytes in which
AcCho alone caused a relatively small conductance increase
(Fig. 2). Here, at a holding potential of -92 mV, AcCho
evoked a net inward current (Fig. 2A); the reversal potential
of this response, as measured by the ramp method (Fig. 2C),
was -53 mV, indicating an increase of both Cl- and K+
conductances (19). During this response, the oocyte's mem-
brane conductance increased by 50% (from 1.6 ,uS at rest to
2.4 ,uS at the plateau of the response). Application of
adenosine (30 min later) resulted in an outward current (Fig.
2B), accompanied by a 300% conductance increase as com-
pared to rest (6.4 ,uS at the plateau ofthe adenosine response;
Fig. 2D). When AcCho was applied in the continuous
presence of adenosine, the outward current was rapidly
transformed into an inward one that had an absolute ampli-
tude (as measured from the resting level of the holding
current) comparable to that seen with AcCho alone (Fig. 2B).
This was also accompanied by a decrease of membrane
conductance to the level seen previously with AcCho alone
(2.4 ,uS; Fig. 2D). Thus, it appears that AcCho indeed blocks
the K+ conductance opened by adenosine; in contrast,
adenosine has no obvious effect on AcCho response.
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FIG. 1. The effect of 1 ,M AcCho on the oocyte's response to 10
,uM adenosine. The oocyte was voltage-clamped at -25 mV (equal
to Vcl, q in this cell). The intervals between the applications shown
in A, B, and C were 35 min. (A) Response of the oocyte to AcCho
alone. (B) Response to adenosine alone. (C) Effect ofAcCho, applied
at the plateau of the adenosine response. To emphasize the AcCho
effect, the records inA andB were superimposed on that in C (dashed
lines; adenosine response was corrected for the slight decrease in
amplitude in C as compared to B).
-90 -70 -50 -30 -90 -70 -50 -30
V, mV
FIG. 2. The inhibition by AcCho of the adenosine-evoked con-
ductance increase. (A) Response of the oocyte to 1 ,uM AcCho.
Holding potential was -92 mV. Numbered arrows indicate the
application of voltage ramps at rest (arrow 1) and at the plateau of
AcCho response (arrow 2). (B) Responses of the same cell 35 min
later. Holding potential as in A. Voltage ramps were applied at rest
(arrow 3), at the plateau of the adenosine (10 ,M) response (arrow
4), and at the peak of the AcCho response (arrow 5). Between the
recordings represented in A and B, the cell was kept at its resting
potential (-48 mV). (C) Voltage-current curves during the applica-
tion of the ramps 1 and 2 shown in A (see Materials and Methods).
(D) Voltage-current curves corresponding to ramps 3-5 shown in B.
Note that extrapolation (broken lines) of the "resting" curve (curve
3) and the curve obtained at the plateau of adenosine response (curve
4) gives an estimate of about -100 mV for the reversal potential of
adenosine response; this is close to the K+ equilibrium potential in
these cells (16).
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Because the adenosine response in the oocyte appears to
be mediated by the activation of adenylate cyclase and
elevation of cAMP level, it seemed probable that AcCho
exerts its inhibitory effect through the inhibition of adenylate
cyclase. Therefore, we tested the effect of AcCho on K+
current evoked by direct intracellular iontophoretic injection
of cAMP (26), thus bypassing the activation of adenylate
cyclase. Application of 1-2 ,uM AcCho at the plateau of
cAMP response suppressed the cAMP-induced current by 95
± 14% (mean ± SD; n = 10), leaving a residual outward
current that, in most cases, approximately equaled the
current produced by AcCho alone (Fig. 3A). This implies that
AcCho blocks the adenosine response at a stage later than the
activation of adenylate cyclase.
AcCho elevates intracellular Ca and cGMP levels in
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FIG. 3. Inhibition by AcCho of the response of an oocyte to
intracellular injection of cAMP (A) and to bath application of
iBuMeXan (B). (A) Holding potential was - 33 mV, about 2 mV more
negative then Vc1,eq in this cell. Recording a: the response to 2 AM
AcCho. Recording b: 35 min later; AcCho was applied at the plateau
of the response to iontophoretic injection of cAMP (30 sec, 105 nA).
Recording c: response of the same oocyte to an additional cAMP
injection (40 sec, 105 nA), 35 min after the beginning of AcCho
washout in recording b. The longer cAMP injection was necessary
because of the long-lasting (up to several hours) "refractory period"
that follows the first cAMP injection, during which the response to
cAMP or adenosine is attenuated (36). (B) Responses of a different
oocyte; holding potential was -21 mV (equal to Vcleq in this cell).
Recording a: Response to 1 AuM AcCho alone. Recording b: AcCho(in Ringer's solution containing 1 mM fBuMeXan) was added at the
plateau of the response evoked by 1 mM iBuMeXan.
various tissues (27) and may thus accelerate cAMP hydrol-
ysis by activating either Ca- or cGMP-dependent phospho-
diesterases. The effect of 3-isobutyl-1-methylxanthine (iBu-
MeXan), a compound known to inhibit both phosphodiester-
ases (28), was therefore tested. iBuMeXan (0.3-1 mM)
significantly enhanced the cAMP response (26, 36) but did
not impair the ability of 1 gM AcCho to inhibit cAMP re-
sponse completely (six cells). Moreover, in some oocytes, 1
mM iBuMeXan alone evoked a K+ current, presumably due to
elevation of the cAMP level; in such cells, AcCho complete-
ly abolished the iBuMeXan-induced outward current (Fig.
3B). Thus, it appears that the inhibitory effect of AcCho is
not mediated by activation of a phosphodiesterase.
Injections of up to 200 pmol of CaCl2 per oocyte, which at
holding potentials of -40 to -50 mV produced Cl- currents
of 50-150 nA, had no effect on the adenosine response (eight
cells; Fig. 4A). Basically negative results were also obtained
with intracellular injections of 0.5-3 pmol of Ins(1,4,5)P3: a
partial inhibition (Fig. 4B) was observed in two cells, and no
effect (as in Fig. 4C) was observed in six oocytes.
The possibility that activation of protein kinase C is
involved in the inhibitory action of AcCho on adenosine and
cAMP responses was tested by use of the phorbol esters PBt2
and PMA. At concentrations up to 3 ,uM, neither of the
phorbol esters elicited Cl- or any other current at any holding
potential in the range tested (-20 to -80 mV). Therefore, in
these experiments the cells were not clamped at Vc1,eq.
Application of 1 ILM PBt2 during the plateau of either
adenosine or cAMP response rapidly and completely sup-
pressed the K+ current (Fig. SA). A similar, but slower or
partial, effect of PBt2 on cAMP response was observed with
0.1 tkM PBt2 [Fig. SB, trace b; 78.6 ± 22.5% inhibition (SD,
n = 5)]. With this concentration of PBt2, an apparent partial
recovery of cAMP response (after the initial drop) was
observed in some cells; this effect was not studied further.
PMA (up to 1 1LM) usually had no obvious immediate effect
when applied at the plateau of adenosine response but
inhibited the response effectively when applied several min-
utes before adenosine (see below).
A
a
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FIG. 4. The effects of intracellular pressure injections of Ca2l
and Ins(1,4,5)P3 on the adenosine response. (A) Holding potential
was -24 mV (equal to Vcicq in this cell); adenosine concentration
was 50 1AM. Recording a: control response to adenosine. Recording
b: effect of injection of 150 pmol of CaC12. (B and C) Lack of effect
ofinjection of Ins(1,4,5)P3 (0.5 pmol in B, 2.5 pmol in C) on adenosine
(20 bLM) response in two different oocytes of the same frog. Holding
potential was -20 mV in both cases.
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FIG. 5. Effects of PBt2 on adenosine (A) and cAMP (B) responses. (A) Holding potential was -35 mV. Recording a: the control response
to 100 A.M adenosine. The reproducibility of the adenosine response was verified by two additional adenosine applications, at 30-min intervals.
Recording b: PBt2 was applied after the third adenosine application, at the plateau of the adenosine response. Recording c: after a 60-min
washout, the adenosine response was still smaller than before the application of PBt2. (B) The control response to iontophoretic cAMP injection
(recording a) and the effect of 0.1 ,uM (recording b) and of 1 1LM (recording c) PBt2 on the cAMP response in three different oocytes of the same
frog. Holding potentials were -40 mV in a, -35 mV in b, and -45 mV in c. Injection current was 180 nA in all cases; injection times were 20
sec in a, 15 sec in b, and 30 sec in c.
Pretreatment of the oocyte for 2-4 min with 20 nM PBt2
caused a 52 ± 16% (SD, n = 3) reduction of the adenosine
response; complete inhibition was attained at 0.1 ,tM. A
15-30 min preincubation with 5 nM PMA resulted in a 73 +
25% (SD; n = 3) inhibition of adenosine response; at 20 nM,
the inhibition was 95 ± 8% (SD; n = 8). The effect of PMA
pretreatment on cAMP response was very similar: a 78 +
16% (SD; n = 6) inhibition at 5 nM, a 87 ± 17% (SD; n = 8)
inhibition at 10 nM, and complete inhibition at .50 nM. The
inhibitory effect of PMA could not be reversed by up to
90-min washings.
DISCUSSION
The mechanism of interactions among hormones and
neurotransmitters acting through second messengers, at the
level of their membrane effects, is not sufficiently explored,
although the importance of such effects can hardly be
questioned. A comprehensive investigation of such interac-
tions requires a preparation that fulfills the following criteria:
(a) the cell's membrane should exhibit well-defined electro-
physiological responses to the substances under study; (b)
the second messenger systems involved in mediation of these
responses should be (at least preliminarily) identified; (c) the
preparation should lend itselfto rigorous electrophysiological
recordings and to manipulations ofthe intracellular content of
the putative second messengers; (d) the preparation should
provide a homogeneous tissue for a biochemical study. X.
Iaevis oocytes appear to fulfill all these criteria (see the
Introduction).' Although the biological role of the membrane
responses to purinergic and cholinergic muscarinic agonists
in this preparation is not known, it seems to be a good model
system for the study of the mechanisms of neurotransmitter
interactions.
In the present study, we showed that AcCho rapidly and
reversibly blocks the increase in K+ conductance evoked
either by the purinergic agonist adenosine or by its putative
second messenger cAMP. The effect of AcCho was blocked
by atropine, suggesting mediation by a muscarinic receptor.
A reverse interaction does not take place; i.e., adenosine
does not inhibit AcCho-evoked Cl- current (the main
muscarinic response in these cells); on the contrary, cAMP
even appears to enhance the second, slow phase of this
response (unpublished observations). Because AcCho is able
to inhibit the cAMP response, we conclude that the inhibition
of adenylate cyclase plays no significant role in the Ac-
Cho-adenosine interaction. This is rather unexpected, as
inhibition of adenylate cyclase by AcCho is believed to be
one of the two mechanisms by which AcCho antagonizes the
effects of adenylate cyclase-activating hormones on cAMP
levels (and, presumably, on the cell membrane) (9, 10).
Another mechanism of antagonism between AcCho and
cAMP-level-elevating hormones, the activation of a cyclic-
nucleotide phosphodiesterase (13), also appears not to be
involved, because AcCho still suppressed the cAMP re-
sponse in the presence of the potent nonspecific phosphodi-
esterase inhibitor iBuMeXan. Moreover, in some oocytes
iBuMeXan elicits an outward current, which probably results
from cAMP-level elevation due to phosphodiesterase inhibi-
tion; yet AcCho inhibits this current, too.
The enhanced breakdown ofphosphoinositides, associated
with the action of AcCho and other Ca-mobilizing agents,
results in the production of two putative second messengers,
Ins(1,4,5)P3 (the Ca-mobilizing agent) and diacylglycerol,
which probably acts synergistically with the increased intra-
cellular Ca to activate protein kinase C (3, 29). As mentioned
above, there is evidence that this mechanism also operates in
Xenopus oocytes (18, 20). The increase in cytoplasmatic
concentration of free Ca alone cannot account for the effect
of AcCho, because intracellularly injected Ca2+ and
Ins(1,4,5)P3 fail to mimic the AcCho effect fully. On the other
hand, PBt2 and PMA inhibit the K+ current elicited by
adenosine or by cAMP. PBt2 and PMA are potent protein
kinase C activators (29), even in the absence of an increased
Ca concentration (30). Other recent studies show that
phorbol esters and protein kinase C have profound effects on
membrane transport mechanisms (31) and on voltage-depen-
dent Ca (32, 33) and K (34) channels. In our experiments,
both phorbol esters were effective at 5-20 nM, concentra-
tions close to those appropriate for specific activation of
protein kinase C (29). These results strongly suggest that
protein kinase C mediates the AcCho antagonism of the
purinergic response.
a
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It is conceivable that protein kinase C acts through phos-
phorylation of a specific protein (29, 35). It is not clear at
present whether this protein itself is a K+ channel or one of
the proteins in the (unknown) chain of reactions that result in
the opening of this channel by cAMP. It is also important to
clarify whether this mechanism of neurotransmitter interac-
tion is universal and to what extent it might account for the
well-known inhibitory action of Ca-mobilizing agents on
hormones and transmitters that elevate cAMP levels.
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